Joseph Gut - thasso
Posted in Children, Genetic Background, Genetic Predisposition, Genetic Susceptibility, New Research, Thasso Post, Theragenomic Medicine
No Comments ↓
June 13, 2020 – To help disentangle the secrets of Covid-19 disease, researchers are sequencing the DNA of young grown-ups and children who suffer from extreme Covid-19 disease ailments in spite of having no hidden clinical issues. The scientists are searching for hereditary genetic risk factors that could put certain people at high danger of getting seriously sick from the novel coronavirus,
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, New Research, Personomics, Thasso Post, Theragenomic Medicine
No Comments ↓
April 28, 2020 – Coronavirus disease 2019 (Covid-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in December 2019 in Wuhan, the capital of China’s Hubei province,
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, New Research, Personomics, Thasso Post, Theragenomic Medicine
1 Comment ↓
Joseph Gut - thasso
Posted in Genetic Background, New Drug Approval, Pediatrics, Rare Diseases, Thasso Post, Theragenomic Medicine
No Comments ↓
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, Thasso Post, Theragenomic Medicine
3 Comments ↓
March 15, 2020 – An international study published in the journal Cell has described 109 genetic variants associated with eight psychiatric disorders such as autism, ADHD, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder and Tourette syndrome in a total of about 230,000 patients worldwide.
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, New Research, Thasso Post, Theragenomic Medicine
No Comments ↓
February 28, 2020 – A very recent report elucidates the possible prospective power of the knowledge about the genetic background of patients when concerned with certain clinical endpoints (disease states) and associated genes.
The researchers in the present study analyzed outcomes in white men enrolled in the E3805 CHAARTED clinical trial according to HSD3B1 genotype,
…
Joseph Gut - thasso
Posted in Gene Expression, Genetic Background, Genetic Susceptibility, New Research, Personalized Medicine, Thasso Post, Theragenomic Medicine
No Comments ↓
March 05, 2020 – Idiopathic pulmonary fibrosis (IPF) is a type of chronic scarring lung disease characterized by a progressive and irreversible decline in lung function. Symptoms typically include gradual onset of shortness of breath and a dry cough.
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, New Research, Thasso Post, Theragenomic Medicine
No Comments ↓
February 27, 2020 – Thiopurines are important antimetabolite drugs, which make up a critical part of curative treatment for ALL. Genetic variations can directly influence drug toxicity and effectiveness of thiopurines. Researchers at St. Jude and elsewhere previously identified NUDT15 variants as a major genetic cause of toxicity during thiopurine therapy,
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Regulatory Approval, Thasso Post, Theragenomic Medicine
No Comments ↓
February 26, 2020 – Fragile X syndrome (FXS) is a genetic disorder characterized by mild-to-moderate intellectual disability.The average IQ in males is under 55, while about two thirds of females are intellectually disabled. Physical features may include a long and narrow face,
…
Joseph Gut - thasso
Posted in Genetic Background, In The Press, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
…
Optional: Social Subscribe/Login
thasso: recent comments